s6y
Company name or ticker
Search
Opus Genetics, Inc.
424B5
Prospectus filed pursuant to Rule 424(b)(5)
Filed
Tuesday, October 15, 2013
Accession number
0001140361-13-038719
Documents
REXAHN PHARMACEUTICALS 424B5 10-10-2013
424B5
On sec.gov
Filing index
All files
Complete submission text
SGML header